Surface Oncology Inc. (SURF): Investors are paying attention to this stock – Invest Chronicle

Surface Oncology Inc. (SURF): Investors are paying attention to this stock

Surface Oncology Inc. (SURF) is priced at $1.76 after the most recent trading session. At the very opening of the session, the stock price was $1.51 and reached a high price of $1.82, prior to closing the session it reached the value of $1.57. The stock touched a low price of $1.51.Recently in News on June 20, 2022, Surface Oncology Announces Publication of New Study Demonstrating the Role of the IL-27 Pathway in Hepatocellular Carcinoma. – Non-clinical findings further support the potential of SRF388 to treat patients suffering from liver cancer -. You can read further details here

Surface Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.1600 on 01/04/22, with the lowest value was $1.3700 for the same time period, recorded on 06/16/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Surface Oncology Inc. (SURF) full year performance was -74.71%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Surface Oncology Inc. shares are logging -79.00% during the 52-week period from high price, and 28.47% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.37 and $8.38.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 835972 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Surface Oncology Inc. (SURF) recorded performance in the market was -63.18%, having the revenues showcasing -38.46% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 89.74M, as it employees total of 67 workers.

The Analysts eye on Surface Oncology Inc. (SURF)

During the last month, 0 analysts gave the Surface Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 2.5903, with a change in the price was noted -1.68. In a similar fashion, Surface Oncology Inc. posted a movement of -48.84% for the period of last 100 days, recording 731,791 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SURF is recording 0.17 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.17.

Technical rundown of Surface Oncology Inc. (SURF)

Raw Stochastic average of Surface Oncology Inc. in the period of last 50 days is set at 26.62%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 52.00%. In the last 20 days, the company’s Stochastic %K was 32.89% and its Stochastic %D was recorded 23.56%.

Considering, the past performance of Surface Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -63.18%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -65.56%, alongside a downfall of -74.71% for the period of the last 12 months. The shares increased approximately by 14.29% in the 7-day charts and went up by -8.33% in the period of the last 30 days. Common stock shares were lifted by -38.46% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts